Table 1.
Clinical outcomes of the 3 age groups.
≤35 years (average age 29.92 years) | 36–37 years (average age 36.44 years) | ≥38 years (average age 40.36 years) | P value | |
Embryo transfer cycles | 5963 | 475 | 571 | |
Cause of infertility | <.05 | |||
Tubal | 4054 (68.0%) | 324 (68.2%) | 385 (67.4%) | |
Endometriosis | 254 (4.3%) | 21 (4.4%) | 11 (1.9%) | |
Ovulatory disorder | 285 (4.8%) | 6 (1.3%) | 5 (0.9%) | |
Decline in ovarian reserve | 202 (3.4%) | 32 (6.7%) | 89 (15.6%) | |
Male factor | 1023 (17.2%) | 55 (11.6%) | 63 (11.0%) | |
Unexplained | 855 (14.3%) | 37 (7.8%) | 18 (3.2%) | |
E2 on the day of FET | 481.84 | 491.41 | 515.97 | >.05 |
P on the day of FET | 24.29 | 23.84 | 21.62 | .024 |
Duration of infertility (yr) | 3.7 ± 0.1 | 5.9 ± 0.5 | 7.7 ± 0.8 | <.001 |
No. thawed embryo | 11,054 | 909 | 1093 | |
No. survived embryo | 10,756 | 888 | 1064 | |
Embryo survival rate | 10,756 (97.3%) | 888 (97.7%) | 1064 (97.3%) | >.05 |
Endometrium preparation | ||||
HRT | 5181 (86.9%) | 437 (92.0%) | 547 (95.8) | <.001 |
NC | 124 (2.1%) | 5 (1.1%) | 2 (0.4%) | |
HMG | 658 (11.0%) | 33 (6.9%) | 22 (3.8%) | |
No. high-quality embryo transfer | 9096 (76.3%) | 718 (75.6%) | 825 (72.2%) | .01 |
Endometrium thickness (mm) | 9.4 ± 0.0 | 9.3 ± 0.1 | 9.1 ± 0.1 | .001 |
Pregnancy rate per cycle | 4003 (67.1%) | 254 (53.5%) | 222 (38.9%) | <.001 |
Implantation rate per cycle | 5449 (45.7%) | 327 (34.4%) | 272 (28.9%) | <.001 |
Live birth rate per cycle | 3554/5963 (59.6%) | 229/475 (48.2%) | 190/571 (33.3%) | <.001 |
Multi pregnancy rate (%) | 1250/3554 (35.2%) | 62/229 (27.1%) | 36/190 (18.9%) | <.001 |
Gestational days (d) | 263.7 ± 0.8 | 263.5 ± 2.8 | 265.3 ± 4.0 | .929 |
Neonatal weight (g) | 3007.2 ± 14.3 | 3137.6 ± 66.9 | 3196.9 ± 72.4 | .005 |
Preterm birth (<37 wks) | 456/3554 (12.8%) | 31/229 (13.5%) | 29/190 (15.3%) | .604 |
E2 = estradiol, FET = frozen-thawed embryo transfers, HMG = human menopausal gonadotropin, HRT = hormone replacement therapy, NC = natural cycle, P = progesterone.